Company Filing History:
Years Active: 2001-2008
Title: Innovations by UmaShanker Sampath: A Look into His Patented Contributions
Introduction
UmaShanker Sampath, a prominent inventor based in Ballwin, MO, has made significant strides in the field of biopharmaceuticals. With three patents to his name, Mr. Sampath has developed innovative processes that are pivotal in the synthesis of important pharmaceutical compounds.
Latest Patents
Mr. Sampath's latest contributions to the industry include two notable patents. The first patent, titled "Process for the production of pentostatin aglycone and pentostatin," presents a novel, scalable, and improved method for preparing pentostatin and its analogs. This method involves the diastereospecific synthesis of the nucleobase using commercially available L-Dialkyl tartarates. The second patent, "Process for the production of 2-halo-6-aminopurine derivatives," introduces an innovative technique for preparing 2-halo-6-aminopurine derivatives and their analogs. This process includes the halogenation of 2,6-diaminopurine derivatives at the C-2 position within a specific combination of aprotic polar and nonpolar organic solvents, leading to the corresponding halogenated derivatives.
Career Highlights
Mr. Sampath serves his expertise at Reliable Biopharmaceutical Corporation, a company known for its commitment to developing cutting-edge biopharmaceutical products. His work focuses on enhancing production processes, thereby contributing positively to the industry.
Collaborations
Throughout his career, UmaShanker Sampath has collaborated with skilled professionals including Lawrence Bartlett and Sourena Nadji. These collaborations have enriched his research and development efforts, facilitating the creation of innovative solutions in biopharmaceutical science.
Conclusion
In conclusion, UmaShanker Sampath stands out as a talented inventor whose patents reflect his commitment to advancing biopharmaceutical processes. His innovative methodologies not only enhance current practices but also hold promise for the future of pharmaceutical development.